FDA Withdraws Some ‘Best Practices’ for Biosimilar Makers

June 26, 2018

Food and Drug Administration withdrew its advice for drugmakers on how they should evaluate the similarity between biologic drugs and their cheaper counterparts, the agency announced on June 21.

Related Stories